Month: May 2023

Vaisala Corporation        Interim Report                        May 5, 2023, at 9.00 a.m. (EEST) Vaisala Corporation Interim Report January–March 2023Year started with strong demand First quarter 2023 highlightsOrders received EUR 132.0 (118.8) million, increase 11% Order book at the end of the period EUR 163.7 (146.1) million, increase 12% Net sales EUR 131.8 (118.8) million, increase 11% Operating result (EBIT) EUR 13.3 (17.5) million, 10.1 (14.8) % of net sales Earnings per share EUR 0.27 (0.38) Cash flow from operating activities EUR 26.9 (9.6) millionMarket development and business outlook for 2023Markets for high-end industrial instruments, life science, power and energy, and liquid measurements are expected to grow. Markets for renewable energy as well as roads and automotive are expected to grow. Market for aviation is expected...

Presentation of updated data on our multiplex shRNA platform, which allows targeting of up to four genes simultaneously Publication of results from the THINK trial, which provided proof-of-concept of our NKG2D-based CAR T-cell approachMONT-SAINT-GUIBERT, Belgium, May 05, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today reports its financial results for the first quarter of 2023 and provides an update on recent business developments. “Celyad Oncology is now fully committed to leveraging its expertise, know-how and intellectual property (IP) portfolio with the goal of providing innovative solutions to overcome the current limitations of CAR T-cell approaches. We have generated...

        Thursday 04 May 2023 REVENUE +11.7% IN Q1 2023 AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer specialising in fluid management, mechanisms and structural parts for electric vehicles, posted consolidated revenue of €274.6m in the first quarter of 2023, up +11.7%. Consolidated revenue for the 1st quarter of 2023 (from 1 January to 31 March)In € millions – unaudited 2023 2022 Variation LFL variation (*)1st quarter 274.6 245.8 +11.7% +14.6%(*) Comparing like-for-like figures With the global automotive market having returned to growth, AKWEL saw its revenue on a like-for-like basis advance +14.6% during the first quarter of the 2023 financial year. The geographical breakdown of revenue by production zone was as follows:France: €77.5m (+10.9%) Europe (excluding France)...

COMMENTARY FROM MANAGEMENT Q1 2023 revenue for Merko Ehitus was EUR 76 million, representing 11% growth compared to the same period a year ago. Net profit for the first quarter was EUR 5.9 million – nearly double that of Q1 2022. Merko delivered 145 apartments to new homeowners in Q1. According to the management of Merko Ehitus, despite the good profit growth in Q1, it had entered a completely different apartment market situation than was in 2020 and 2021 when transaction volume and prices peaked. Today are drawing up the final contracts under property law for apartments pre-sold earlier, and this is also showing up in current financial results. The pace of new sales of apartments has dropped steeply compared to spring 2022 and is several times lower than before. Because of that, Merko group has launched fewer development projects in the...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Q1 2023 sales increased by 1 % in local currency, down 5 % in Swiss francs to CHF 1.200 billion – positive pricing contribution of 7 % Q1 2023 EBITDA down 24 % to CHF 167 million, EBITDA margin of 13.9 %, mainly attributable to 7 % lower volumes and business mix, CHF 13 million negative sunliquid® impact, and a CHF 11 milllion negative one-off fair value adjustment of the Heubach Group participation Closing of North American Land Oil business divestment on 31 March 2023  Unchanged Outlook 2023“Clariant delivered a resilient top-line result in the first quarter, despite the macroeconomic headwinds. Our customers have reduced their inventory, and demand in some areas has been weaker, which, coupled with the negative extraordinary factors recorded in the quarter, impacted our profitability. Overall,...

 Audited full year 2022 annual financial figures due to be reported by end of May 2023Basel, Switzerland, May 5, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and ophthalmic diseases, today reported unaudited key financial figures for the year ended 31 December 2022 of Kinarus Therapeutics Group. The audited full year 2022 financial figures are due to be reported by end of May 2023 On 28 April 2023, Kinarus announced that the SIX Exchange Regulation (“SER”) approved a deadline extension until the end of May 2023 for the publication of the Kinarus’ 2022 annual report. In its decision, SER asked Kinarus to report unaudited key financial figures for the consolidated financial statements of Kinarus Therapeutics...

May 5, 2023 FIRST QUARTER 2023  STRONG REVENUE GROWTH AND IMPROVEMENT OF OPERATING RESULT   POSITIVE ADJUSTED OPERATING FREE CASH FLOW AT €0.7 BILLION DRIVEN BY STRONG SUMMER TICKET SALES  Strong demand with 19.7m passengers onboard, up 35% versus 2022 Group revenues at €6.3bn, an improvement of €1.9bn (+42%) compared to last year thanks to continuous strong market demandGroup unit cost1 per ASK stable at +0.7% versus 2022Operating result at –€0.3bn with operating margin at –4.8%, above 2022 level (-7.9%)Positive Adjusted operating free cash flow at €0.7bn and solid cash at hand at €9.7bnNet debt down by €0.9bn euros, compared to end of 2022 Continued deleveraging: Net debt/EBITDA ratio at 1.5x versus 1.8x end of 2022Commenting on the results, Mr. Benjamin Smith, Group CEO, said:” In the first quarter, Air...

Oslo, 5 May 2023: In the first quarter 2023, Scatec’s proportionate revenues rose to NOK 2,706 million (809), with a 92 percent increase in EBITDA to NOK 765 million compared to the first quarter last year. Power production was 887 GWh (868) and the proportionate power production EBITDA rose by 40 percent to NOK 686 million (490), mainly driven by the Philippines. “We are pleased with a solid start to the year, driven by strong operational and financial performance. Scatec delivered high power production availability in the quarter and without any injuries. We also report solid progression and strong margins of 11 percent for our projects under construction in South Africa, Brazil, and Pakistan. We will continue to deliver on our strategy with a focused and disciplined approach providing renewables projects with attractive returns. The...

TORONTO, May 04, 2023 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB.G, FC.DB,H, FC.DB.I, FC.DB.J ,FC.DB. K and FC.DB.L) released its financial statements for the three months ended March 31, 2023. NET INCOMEFor the three months ended March 31, 2023, net income increased by 10.8% to $8,711,897 as compared to $7,861,540 reported for the same period in 2022. The increase is primarily a result of a higher average interest rate on the Corporation’s Investment Portfolio (March 31, 2023 – 11.15% vs March 31, 2022 – 8.05%). EARNINGS PER SHAREBasic weighted average profit per share for the three months ended March 31, 2023, was $0.253, as compared to the $0.232 per share reported for the three months ended March 31, 2022. PORTFOLIOThe Corporation’s Investment Portfolio decreased by $9.2...